Hemostasis in pregnant women with COVID-19

Pregnancy is a prothrombotic condition characterized by a procoagulant imbalance that serves to protect women from bleeding but increases their risk for venous thromboembolism (VTE) [1]. Coronavirus disease 2019 (COVID-19) has not spared pregnant women with regards to VTE [2]. A coagulopathy that increases the risk of thrombosis has been reported in patients with severe COVID-19 infection [3]. At present, no data are available on the hemostatic status of pregnant women with COVID-19, and whether coagulation parameters are additionally influenced by COVID-19 remains unclear.